Compare · ALTG vs TMO
ALTG vs TMO
Side-by-side comparison of Alta Equipment Group Inc. (ALTG) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALTG and TMO operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- TMO is the larger of the two at $176.13B, about 851.2x ALTG ($206.9M).
- Over the past year, ALTG is up 17.0% and TMO is up 17.4% - TMO leads by 0.4 points.
- TMO has been more active in the news (19 items in the past 4 weeks vs 7 for ALTG).
- TMO has more recent analyst coverage (25 ratings vs 8 for ALTG).
- Company
- Alta Equipment Group Inc.
- Thermo Fisher Scientific Inc
- Price
- $6.36-0.93%
- $473.94-1.69%
- Market cap
- $206.9M
- $176.13B
- 1M return
- -17.56%
- +2.47%
- 1Y return
- +17.02%
- +17.39%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 7
- 19
- Recent ratings
- 8
- 25
Alta Equipment Group Inc.
Alta Equipment Group Inc. owns and operates integrated equipment dealership platforms in the United States. It operates in two segments, Material Handling and Construction Equipment. The company operates a branch network that sells, rents, and provides parts and service support for various categories of specialized equipment, including lift trucks and aerial work platforms, cranes, earthmoving equipment, and other material handling and construction equipment. It also offers repair and maintenance services for its equipment. In addition, the company designs and builds warehouses, as well as provides automated equipment installation and system integration solutions. It serves diversified manufacturing, food and beverage, wholesale/retail, construction, automotive, municipal/government, and medical sectors. Alta Equipment Group Inc. was founded in 1984 and is based in Livonia, Michigan.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest ALTG
- Director Shribman Daniel was granted 14,903 shares, increasing direct ownership by 4% to 361,796 units (SEC Form 4)
- Director White Katherine E was granted 14,903 shares, increasing direct ownership by 22% to 82,204 units (SEC Form 4)
- Director Studdert Andrew P was granted 14,903 shares, increasing direct ownership by 13% to 131,716 units (SEC Form 4)
- Director Nair Sidhartha was granted 14,903 shares, increasing direct ownership by 39% to 52,709 units (SEC Form 4)
- Director Wilson Colin was granted 14,903 shares, increasing direct ownership by 51% to 43,937 units (SEC Form 4)
- Alta Equipment Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- SEC Form EFFECT filed by Alta Equipment Group Inc.
- Amendment: SEC Form S-3/A filed by Alta Equipment Group Inc.
- SEC Form 10-Q filed by Alta Equipment Group Inc.
- Alta Equipment Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
Latest TMO
- Thermo Fisher downgraded by HSBC Securities with a new price target
- Wolfe Research resumed coverage on Thermo Fisher with a new price target
- SEC Form SD filed by Thermo Fisher Scientific Inc
- Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
- Thermo Fisher Scientific Inc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Director Weisler Dion J covered exercise/tax liability with 80 shares and was granted 499 shares, increasing direct ownership by 8% to 5,446 units (SEC Form 4)
- Director Sperling Scott M was granted 499 shares, increasing direct ownership by 0.72% to 69,479 units (SEC Form 4)
- Director Spar Debora L was granted 499 shares, increasing direct ownership by 24% to 2,610 units (SEC Form 4)
- Director Lynch Karen S was granted 499 shares, increasing direct ownership by 76% to 1,159 units (SEC Form 4)
- Director Keith R. Alexandra was granted 499 shares, increasing direct ownership by 24% to 2,602 units (SEC Form 4)